The epidemiological characteristics of measles and challenges of measles elimination in Hang Zhou, China

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 6, 2013, Pages 1296-1302

  Liu, Shijun ^a   Xu, Erping ^a,b   Zhang, Xiaoping ^a   Liu, Yan ^a   Du, Jian ^a   Wang, Jun ^a   Che, Xinren ^a   Gu, Wenwen ^a  

^a Hangzhou Center for Disease Control and Prevention   (China)

^b NONE   (China)

Author keywords

Descriptive epidemiology; Immunization strategy; Measles; Measles elimination

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHINA; DESCRIPTIVE RESEARCH; DISEASE ELIMINATION; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; POPULATION MIGRATION; TREND STUDY; URBAN AREA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; DISEASE ERADICATION; FEMALE; HUMAN MIGRATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MEASLES; MIDDLE AGED; RISK FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84880659872     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24032     Document Type: Article

References (20)

1. ChaoM, LixinH, JingM, YanZ, LeiC, XiaofengL, et al.Measles Epidemiological Characteristics and Progress of Measles Elimination in China, 2010.[Chinese]. Chinese Journal of Vaccine and Immunization.2011; 17:242-8.
2. ChiuHH, LeeCY, ChihTW, LeePI, ChangLY, LinYJ, et al.Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.J Med Virol1997; 51:32-5; PMID:8986946; http://dx.doi.org/10.1002/(SICI)1096- 9071(199701)51:13.0.CO;2-T.
3. Centers for Disease Control and Prevention (CDC). International Notes Nutritional and Health Status of Displaced Persons, Sudan, 1988-1989.MMWR Weekly1989; 38:848-50.
4. MoorePS, MarfinAA, QuenemoenLE, GessnerBD, AyubYS, MillerDS, et al.Mortality rates in displaced and resident populations of central Somalia during 1992 famine.Lancet1993; 341:935-8; PMID:8096276; http://dx.doi.org/10. 1016/0140-6736(93)91223-9.
5. TooleMJ, WaldmanRJ. An analysis of mortality trends among refugee populations in Somalia, Sudan, and Thailand.Bull World Health Organ1988; 66(2):237-47; PMID:3260831.
6. ChaoM, HuimingL, ZhijieA, PingZ, NingW, WeiX, et al.Analysis on Epidemiological Characteristics and Measures of Measles Control in China During 2006-2007.[Chinese]. Chinese Journal of Vaccine and Immunization.2010; 14:208-13.
7. KouadioIK, KamigakiT, OshitaniH. Measles outbreaks in displaced populations: a review of transmission, morbidity and mortality associated factors.BMC Int Health Hum Rights2010; 10:5; PMID:20298611; http://dx.doi.org/ 10.1186/1472-698X-10-5.
8. World Health Organization. Fifty-fourth session of the regional committee for the western pacioc. Summary record of the ofth meeting. Resolution WPR/RC54.R3. Expanded programme on immunization: measles and hepatitis B. Manila, Philippines: WHO, 2003. http://www.wpro.who.int/rcm/en/archives/rc54/rc- resolutions/wpr-rc54-r03.htm
9. MossWJ, GriffinDE. Measles.Lancet2012; 379:153-64; PMID:21855993; http://dx.doi.org/10.1016/S0140-6736(10)62352-5.
10. FinePE, ClarksonJA. Measles in England and Wales-I: An analysis of factors underlying seasonal patterns.Int J Epidemiol1982; 11:5-14; PMID:7085179; http://dx.doi.org/10.1093/ije/11.1.5.
11. FerrariMJ, GraisRF, BhartiN, ConlanAJK, BjørnstadON, WolfsonLJ, et al.The dynamics of measles in sub-Saharan Africa.Nature2008; 451:679-84; PMID:18256664; http://dx.doi.org/10.1038/nature06509.
12. ZhuHL, JiJM, HeB, LinY, GaoWJ, FuXF, et al.Investigation on antibody level of measles and influencing factors among adults in Jiangxing, Zhejiang.[Chinese]. Chin Prev Me.2012; 13:527-9.
13. ChengJ, HuoXX, ZhangHC, ZhanFX, YangBF, ZhanJB. Analysis of immune levels against measles, rubella and mumps in healthy population in Hubei province.Chinese Journal of Health Laboratory Technology; 21: 2737-41.
14. HershBS, MarkowitzLE, MaesEF, FunkhouserAW, BaughmanAL, SirotkinBI, et al.The geographic distribution of measles in the United States, 1980 through 1989.JAMA1992; 267:1936-41; PMID:1548826; http://dx.doi.org/10.1001/jama.1992. 03480140062034.
15. MartinsCL, GarlyML, BaléC, RodriguesA, RavnH, WhittleHC, et al.Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.BMJ2008; 337:a661; PMID:18653640; http://dx.doi.org/10.1136/bmj.a661.
16. GansH, YasukawaL, RinkiM, DeHovitzR, ForghaniB, BeelerJ, et al.Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.J Infect Dis2001; 184:817-26; PMID:11528592; http://dx.doi.org/10.1086/323346.
17. KumarML, JohnsonCE, ChuiLW, WhitwellJK, StaehleB, NalinD. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers.Vaccine1998; 16:2047-51; PMID:9796063; http://dx.doi.org/10.1016/S0264- 410X(98)00083-8.
18. AabyP, MartinsCL, GarlyML, RodriguesA, BennCS, WhittleH. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.BMJ Open2012; 2:e000761.http://dx.doi. org/10.1136/bmjopen-2011-000761; PMID:22815465
19. ZhangX, ShirayamaY, ZhangY, BaW, IkedaN, MoriR, et al.Duration of maternally derived antibody against measles: a seroepidemiological study of infants aged under 8 months in Qinghai, China. Vaccine2012; 30:752-7; PMID:22133513; http://dx.doi.org/10.1016/j.vaccine.2011.11.078.
20. TumwineJK. Measles in Chimanimani Zimbabwe. East Afr Med J1989; 66:531-4; PMID:2606038.